Brainstorm Cell Therapeutics Secures $1 Million in Private Placement Funding
Amount Raised
$1 Million
Round Type
Post-IPO Equity
New YorkBiotechnologyHealth CareTherapeuticsresearchDescription
On February 9, 2026, Brainstorm Cell Therapeutics Inc. entered into a Securities Purchase Agreement with an accredited investor. The agreement involves two closings, with a total subscription amount of $1,000,000 for shares of the company's common stock. The purchase will occur in two separate closings of $500,000 each.
Who else raised in Therapeutics and research around the same time
Companies in the same sectors as Brainstorm Cell Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Faeth Therapeutics raised $200M (Post-IPO Equity) on February 18, 2026.
- Oncomatryx Biopharma raised $67M (Corporate Round) on March 30, 2026.
- Marvel Biosciences raised $476K (Grant) on March 30, 2026.
- Pinnacle Medicines raised $89M (Series B) on March 26, 2026.
- Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
- RyboDyn raised $10M (Seed) on March 24, 2026.
Who to call at Brainstorm Cell Therapeutics, and when
A new round usually means Brainstorm Cell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Brainstorm Cell Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Brainstorm Cell Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Brainstorm Cell Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Brainstorm Cell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Brainstorm Cell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.